Literature DB >> 11704974

Animal models for osteoporosis.

R T Turner1, A Maran, S Lotinun, T Hefferan, G L Evans, M Zhang, J D Sibonga.   

Abstract

Animal models will continue to be important tools in the quest to understand the contribution of specific genes to establishment of peak bone mass and optimal bone architecture, as well as the genetic basis for a predisposition toward accelerated bone loss in the presence of co-morbidity factors such as estrogen deficiency. Existing animal models will continue to be useful for modeling changes in bone metabolism and architecture induced by well-defined local and systemic factors. However, there is a critical unfulfilled need to develop and validate better animal models to allow fruitful investigation of the interaction of the multitude of factors which precipitate senile osteoporosis. Well characterized and validated animal models that can be recommended for investigation of the etiology, prevention and treatment of several forms of osteoporosis have been listed in Table 1. Also listed are models which are provisionally recommended. These latter models have potential but are inadequately characterized, deviate significantly from the human response, require careful choice of strain or age, or are not practical for most investigators to adopt. It cannot be stressed strongly enough that the enormous potential of laboratory animals as models for osteoporosis can only be realized if great care is taken in the choice of an appropriate species, age, experimental design, and measurements. Poor choices will results in misinterpretation of results which ultimately can bring harm to patients who suffer from osteoporosis by delaying advancement of knowledge.

Entities:  

Keywords:  NASA Discipline Regulatory Physiology; Non-NASA Center

Mesh:

Year:  2001        PMID: 11704974     DOI: 10.1023/a:1010067326811

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  37 in total

1.  Monitoring skeletal changes by radiological techniques.

Authors:  C C Glüer
Journal:  J Bone Miner Res       Date:  1999-11       Impact factor: 6.741

2.  Prednisolone alone, or in combination with estrogen or dietary calcium deficiency or immobilization, inhibits bone formation but does not induce bone loss in mature rats.

Authors:  V Shen; R Birchman; X G Liang; D D Wu; R Lindsay; D W Dempster
Journal:  Bone       Date:  1997-10       Impact factor: 4.398

3.  A new way to induce oestrogen-deficiency osteopaenia in the rat: comparison of the effects of surgical ovariectomy and administration of the LHRH agonist buserelin on bone resorption and composition.

Authors:  A Goulding; E Gold
Journal:  J Endocrinol       Date:  1989-05       Impact factor: 4.286

4.  Effects of anti-estrogens on bone in castrated and intact female rats.

Authors:  V C Jordan; E Phelps; J U Lindgren
Journal:  Breast Cancer Res Treat       Date:  1987-10       Impact factor: 4.872

5.  Expression profiles of mRNAs for osteoblast and osteoclast proteins as indicators of bone loss in mouse immobilization osteopenia model.

Authors:  J Rantakokko; H Uusitalo; T Jämsä; J Tuukkanen; H T Aro; E Vuorio
Journal:  J Bone Miner Res       Date:  1999-11       Impact factor: 6.741

6.  Alcohol consumption inhibits bone growth and development in young actively growing rats.

Authors:  H W Sampson; N Perks; T H Champney; B DeFee
Journal:  Alcohol Clin Exp Res       Date:  1996-11       Impact factor: 3.455

7.  Zoledronate prevents the development of absolute osteopenia following ovariectomy in adult rhesus monkeys.

Authors:  N Binkley; D Kimmel; J Bruner; A Haffa; B Davidowitz; C Meng; V Schaffer; J Green
Journal:  J Bone Miner Res       Date:  1998-11       Impact factor: 6.741

8.  Skeletal alterations in ovariectomized rats.

Authors:  T J Wronski; P L Lowry; C C Walsh; L A Ignaszewski
Journal:  Calcif Tissue Int       Date:  1985-05       Impact factor: 4.333

9.  Differentiating between orchiectomized rats and controls using measurements of trabecular bone density: a comparison among DXA, histomorphometry, and peripheral quantitative computerized tomography.

Authors:  H N Rosen; S Tollin; R Balena; V L Middlebrooks; W G Beamer; L R Donohue; C Rosen; A Turner; M Holick; S L Greenspan
Journal:  Calcif Tissue Int       Date:  1995-07       Impact factor: 4.333

10.  Genetic variability in adult bone density among inbred strains of mice.

Authors:  W G Beamer; L R Donahue; C J Rosen; D J Baylink
Journal:  Bone       Date:  1996-05       Impact factor: 4.398

View more
  49 in total

1.  Influence of creatine supplementation on bone quality in the ovariectomized rat model: an FT-Raman spectroscopy study.

Authors:  Renato Aparecido de Souza; Murilo Xavier; Fabiano Fernandes da Silva; Marco Túlio de Souza; Maira Gaspar Tosato; Airton Abrahão Martin; Julio Cezar de Melo Castilho; Wellington Ribeiro; Landulfo Silveira
Journal:  Lasers Med Sci       Date:  2011-08-12       Impact factor: 3.161

2.  Impact of a functionalized olive oil extract on the uterus and the bone in a model of postmenopausal osteoporosis.

Authors:  Annekathrin Martina Keiler; Oliver Zierau; Ricardo Bernhardt; Dieter Scharnweber; Nikolaos Lemonakis; Aikaterini Termetzi; Leandros Skaltsounis; Günter Vollmer; Maria Halabalaki
Journal:  Eur J Nutr       Date:  2013-10-30       Impact factor: 5.614

3.  Mice chronically fed a westernized experimental diet as a model of obesity, metabolic syndrome and osteoporosis.

Authors:  Christian Demigné; May Bloch-Faure; Nicolas Picard; Houda Sabboh; Catherine Besson; Christian Rémésy; Valérie Geoffroy; Anh-Thu Gaston; Antonino Nicoletti; Albert Hagège; Joël Ménard; Pierre Meneton
Journal:  Eur J Nutr       Date:  2006-04-28       Impact factor: 5.614

4.  Progressive ossification of the bone marrow vasculature with advancing age corresponds with reduced red blood cell count and percentage of circulating lymphocytes in male Fischer-344 rats.

Authors:  Sophie Guderian; Seungyong Lee; Mary Ann McLane; Rhonda D Prisby
Journal:  Microcirculation       Date:  2019-06-17       Impact factor: 2.628

5.  Genistein administered as a once-daily oral supplement had no beneficial effect on the tibia in rat models for postmenopausal bone loss.

Authors:  Russell T Turner; Urszula T Iwaniec; Juan E Andrade; Adam J Branscum; Steven L Neese; Dawn A Olson; Lindsay Wagner; Victor C Wang; Susan L Schantz; William G Helferich
Journal:  Menopause       Date:  2013-06       Impact factor: 2.953

6.  Regional variations of jaw bone characteristics in an ovariectomized rat model.

Authors:  Keiichiro Watanabe; Samantha Lewis; Xiaohan Guo; Ai Ni; Beth S Lee; Toru Deguchi; Do-Gyoon Kim
Journal:  J Mech Behav Biomed Mater       Date:  2020-06-29

7.  Characterization of a rabbit osteoporosis model induced by ovariectomy and glucocorticoid.

Authors:  Li Baofeng; Yuan Zhi; Chen Bei; Meng Guolin; Yin Qingshui; Liu Jian
Journal:  Acta Orthop       Date:  2010-06       Impact factor: 3.717

Review 8.  The effect of icariin on bone metabolism and its potential clinical application.

Authors:  Z Wang; D Wang; D Yang; W Zhen; J Zhang; S Peng
Journal:  Osteoporos Int       Date:  2017-11-06       Impact factor: 4.507

9.  The biomaterial-mediated healing of critical size bone defects in the ovariectomized rat.

Authors:  S F Durão; P S Gomes; B J Colaço; J C Silva; H M Fonseca; J R Duarte; A C Felino; M H Fernandes
Journal:  Osteoporos Int       Date:  2014-02-27       Impact factor: 4.507

10.  Hypothalamic suppression decreases bone strength before and after puberty in a rat model.

Authors:  Vanessa Yingling; McKayla Elle Saine; Rupali Joshi
Journal:  Calcif Tissue Int       Date:  2009-04-07       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.